Cilostazol for secondary stroke prevention: systematic review and meta-analysis

Código QR

Cilostazol for secondary stroke prevention: systematic review and meta-analysis

Guardado en:

Detalles Bibliográficos
Autores principales:	Leonard LL Yeo, Choon Han Tan, Ching-Hui Sia, Aloysius ST Leow, Vijay Kumar Sharma, Benjamin YQ Tan, Andrew GR Wu, Bernard PL Chan
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/47bf2740c30c4d9c8f2852d920881412
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Effect of cilostazol on arteriovenous fistula in hemodialysis patients
por: Jae Wan Jeon, et al.
Publicado: (2021)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Travis M Falconer, et al.
Publicado: (2008)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
por: E. Y. Kitaeva, et al.
Publicado: (2017)

TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
por: Muhammad Tariq, et al.
Publicado: (2018)

Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats
por: Toshikazu Ito, et al.
Publicado: (2021)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Lei Zhang, et al.
Publicado: (2021)

Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes.
por: Nicholas J Leeper, et al.
Publicado: (2013)

Participants’ Perspective of Engaging in a Gym-Based Health Service Delivered Secondary Stroke Prevention Program after TIA or Mild Stroke
por: Maria Sammut, et al.
Publicado: (2021)

The role of cilostazol, a phosphodiesterase 3 inhibitor, on oocyte maturation and subsequent pregnancy in mice.
por: Min Li, et al.
Publicado: (2012)

Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
por: Masafumi Ihara, et al.
Publicado: (2014)

Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings: a decision analysis
por: A.L. Berkowitz, et al.
Publicado: (2015)

Comparison of Traditional Chinese Medicine in the Long-Term Secondary Prevention for Patients with Ischemic Stroke: A Systematical Analysis
por: Jiali Li, et al.
Publicado: (2021)

A Systematic Approach to the Development of Cilostazol Nanosuspension by Liquid Antisolvent Precipitation (LASP) and Its Combination with Ultrasound
por: Emilia Jakubowska, et al.
Publicado: (2021)

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
por: Ikushima I, et al.
Publicado: (2011)

Seeking healthcare services post-stroke: a qualitative descriptive study exploring family caregiver and stroke survivor perspectives in an asian setting
por: Shilpa Tyagi, et al.
Publicado: (2021)

Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
por: Werner M Maokola, et al.
Publicado: (2021)

Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion
por: Akihiro Kitamura, et al.
Publicado: (2017)

Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.
por: Hye Young Kim, et al.
Publicado: (2014)

Neurite outgrowth mediated by translation elongation factor eEF1A1: a target for antiplatelet agent cilostazol.
por: Kenji Hashimoto, et al.
Publicado: (2011)

Precision antiplatelet therapy for the prevention of ischaemic stroke
por: David Wang

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Saleh A. Alqahtani, et al.
Publicado: (2021)

Cilostazol renoprotective effect: modulation of PPAR-γ, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusion.
por: Diaa Ragab, et al.
Publicado: (2014)

Adherence to Secondary Prevention and Influential Factors in Individuals with Coronary Angioplasty
por: Vanesa Henao López, et al.
Publicado: (2020)

Esophageal variceal ligation in the primary and secondary prevention of variceal bleeding
por: D. B. Dashatsyrenova, et al.
Publicado: (2017)

THE ROLE OF CYTOLOGICAL AND VIROLOGICAL STUDIES IN SECONDARY PREVENTION OF CERVICAL CANCER
por: E. V. Bahidze, et al.
Publicado: (2014)

10th Anniversary of Asia Pacific Stroke Organization: State of Stroke Care and Stroke Research in the Asia Pacific
por: Kay-Sin Tan, et al.
Publicado: (2021)

The development of a mobile phone based intervention to improve adherence to secondary prevention of coronary heart disease in China
por: S. Chen, et al.
Publicado: (2016)

Secondary Prevention of Dementia: Combining Risk Factors and Scalable Screening Technology
por: Triin Ojakäär, et al.
Publicado: (2021)

Early predictors and prevention for post-stroke epilepsy: changes in neurotransmitter levels
por: Xie Wen-Jing, et al.
Publicado: (2016)

The incidence of myocardial infarction and stroke in head and neck cancer patients
por: Hyun-Keun Kwon, et al.
Publicado: (2021)

Comparison of Coronary Heart Disease and Stroke in Association with Diabetic Retinopathy in Adults with Diabetes Using a National Survey
por: Yang GR, et al.
Publicado: (2020)

Detection of Secondary Metabolites as Biomarkers for the Early Diagnosis and Prevention of Type 2 Diabetes
por: Al-Aama JY, et al.
Publicado: (2019)

Barriers and challenges for primary and secondary prevention of heart disease in sub-Saharan Africa
por: Simon Stewart, et al.
Publicado: (2017)

PREVALENCE, PREVENTION, AND WOUND CARE OF PRESSURE INJURY IN STROKE PATIENTS IN THE NEUROLOGY WARD
por: Rini Riandini, et al.
Publicado: (2018)

Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models.
por: Christa Thoene-Reineke, et al.
Publicado: (2011)

Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A
por: Kadhim Al-Banaa, et al.
Publicado: (2021)

Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands.
por: Jelena Stevanović, et al.
Publicado: (2014)

Baerveldt implant for secondary glaucoma due to iris melanoma
por: Annelie N Tan, et al.
Publicado: (2010)

Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic
por: Noorhida Baharudin, et al.
Publicado: (2021)